Harvard Bioscience Announces Fourth Quarter 2019 Financial Results
February 26, 2020 07:15 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the three and twelve months ended December 31, 2019....
Harvard Bioscience Schedules Fourth Quarter 2019 Earnings Conference Call for February 26, 2020 at 8:00 AM ET
February 11, 2020 17:15 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Feb. 11, 2020 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for fourth quarter ended December 31, 2019 before the market opens on...
Harvard Bioscience to attend Benchmark’s 8th Annual Discovery One-on-One Conference
November 21, 2019 16:45 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Nov. 21, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), today announced that Jim Green, Chairman, President and CEO, and Michael Rossi, CFO will attend The...
Harvard Bioscience Announces Third Quarter Financial Results
November 05, 2019 16:00 ET
|
Harvard Bioscience, Inc.
Improves adjusted operating margins while taking actions to underpin next year’s profit and growth targets Q3 Revenue of $27.4 millionQ3 Operating Loss (GAAP) of $(1.4) million; Adjusted Operating...
Harvard Bioscience Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 01, 2019 08:15 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Nov. 01, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) announced today that in connection with Yash Singh being named Executive Vice President, Cellular &...
Harvard Bioscience Announces Executive Appointment
October 31, 2019 17:10 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) announced today that Yash Singh has been named Executive Vice President, Cellular & Molecular...
Harvard Bioscience Schedules Third Quarter 2019 Earnings Conference Call for November 5 at 4:30 PM ET
October 22, 2019 18:31 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Oct. 22, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its quarterly results for third quarter ended September 30, 2019 after market close on...
Harvard Bioscience Announces Executive Appointment
October 21, 2019 08:45 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Oct. 21, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) announced today that Ken Olson has been named Vice President and General Manager, Pre-Clinical Systems...
Harvard Bioscience Announces Strategic Action Plan and Financial Targets
September 09, 2019 08:00 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Sept. 09, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announces its strategic action plan and financial targets for rest of year 2019 through 2021. Key...
Harvard Bioscience Elects Alan Edrick to Board of Directors
September 04, 2019 16:45 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) announced today that its Board of Directors has elected Alan Edrick to Harvard Bioscience’s Board of...